Ocugen OCGN
NASDAQ OCGN
$0.96 +0.01 (+1.09%)
At close: Nov 11, 2026 · 4:00 PM EST

Ocugen (OCGN) Asset Writedowns and Impairment (2019)

Updated

Ocugen's Asset Writedowns and Impairment came in at $4.07 million for FY2023.

Analysis

Ocugen (OCGN) Asset Writedowns and Impairment (2019) Analysis & Trends

Going back to FY2014, Ocugen's Asset Writedowns and Impairment data covers 4 years.

  • The FY2023 figure represents the lowest annual Asset Writedowns and Impairment since FY2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Ocugen 322.34 Mn 87.56 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2019 750,000.00
API Access

Ocugen Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=OCGN&period=max&api_key=YOUR_API_KEY